DIA Biosimilars 2013

Genesis Biopharma

Genesis Biopharma names Bishop executive chairman

Friday, March 23, 2012 03:12 PM

Genesis Biopharma, a biotechnology company developing targeted cancer immunotherapies, appointed Hans E. Bishop executive chairman of the company's board of directors.

More... »

Cenduit: Now with Patient Reminders

Genesis names Voyticky to board of directors

Wednesday, July 20, 2011 11:50 AM

Genesis Biopharma has named David Voyticky to its board of directors. Voyticky is currently president of Miller Energy Resources, an oil and gas exploration company, and has more than 16 years of experience in corporate finance and merger and acquisition consulting.

More... »

CRF Health – eCOA Forum

Radvanyi joins Genesis Biopharma

Wednesday, July 6, 2011 10:19 AM

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has named Laszlo Radvanyi, Ph.D., to its Scientific and Medical Advisory Board.

More... »

Patrick Hwu and Mario Sznol join Genesis Biopharma's advisory board

Friday, May 27, 2011 12:07 PM

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, note that Patrick Hwu, M.D., and Mario Sznol, M.D., have joined the company's recently formed scientific and medical advisory board.

More... »

Genesis Biopharma names L. Stephen Coles to board of directors

Tuesday, March 1, 2011 08:00 AM

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has appointed L. Stephen Coles, M.D., Ph.D., to the company's board of directors. 

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs